Back

Drug-coated balloon strategy and major bleeding in high-bleeding-risk acute coronary syndrome

29 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Complex decisions in revascularisation: age, extent, and device strategy Revascularisation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Junki Yabuta

(Japan)

6 More presentations in this session

Presentation thumbnail
Is there an acceptable level of incomplete revascularization after PCI in elderly ACS?
Doctor B. Bahtiyar (Ankara, TR)
Abstract Slides
Presentation thumbnail
Complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease: 10-year outcome from the DANAMI-3–PRIMULTI trial
Doctor Y. Zhou (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Perioperative colchicine increases hospital-acquired infections without reducing major cardiovascular complications in patients undergoing coronary artery bypass grafting after acute coronary syndrome
Mr L. Cartaxo Sampaio (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Antiplatelet regimen in patients with drug-coated balloons for coronary in-stent restenosis: insights from the REC-CAGEFREE II trial
Doctor C. Gao (Hefei, CN)
Presentation thumbnail
Ageism camouflaged as medical judgment – why is PCI reserved for more stable elderly ACS patients?
Doctor T. Filipovic (RS)
Abstract Slides

Access the full session

Session thumbnail
Complex decisions in revascularisation: age, extent, and device strategy

The Event

Event poster

ESC Congress 2026

29 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Ticagrelor or prasugrel in patients with acute coronary syndrome and high bleeding risk
27 August 2022
thumbnail
Congress Presentation
Drug-coated balloon versus drug-eluting stent following orbital atherectomy for calcified coronary artery: one-year outcomes of a retrospective cohort study
27 August 2021
thumbnail
Congress Presentation
Percutaneous coronary intervention using sirolimus eluting balloons in patients at high bleeding risk: Evidence from the SELUTION DeNovo trial
29 August 2026
thumbnail
Congress Presentation
What makes it stentless? Development and internal validation of bailout risk score in DCB-only PCI
19 February 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources